. These studies have also demonstrated central roles for myosin II in cell locomotion and in maintenance of cortical tension (17, 27, 38) . Although the roles of myosin II in nonmuscle cells are generally becoming clear, the mechanisms regulating localization and activity of myosin II in these settings are not well understood. Myosin light chain (MLC) 1 phosphorylation has a clear role in regulating mammalian smooth and nonmuscle myosin II motor function, and is also thought to participate in regulation of filament assembly in nonmuscle cells (36). Although phosphorylation of the myosin II heavy chain (MHC) has also been observed in several types of mammalian nonmuscle cells in a variety of settings (4, 18, 23, 26) , the de-
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'ON~USCLE myosin II is a major component of the cytoskeleton in eukaryotic cells, and is involved or implicated in a wide range of contractile events (34) . In Dictyostelium discoideum, genetic and cellular studies have demonstrated essential roles for myosin II in cytokinesis, multicellular development, and receptor capping (7, 12, 27) . These studies have also demonstrated central roles for myosin II in cell locomotion and in maintenance of cortical tension (17, 27, 38) . Although the roles of myosin II in nonmuscle cells are generally becoming clear, the mechanisms regulating localization and activity of myosin II in these settings are not well understood. Myosin light chain (MLC) 1 phosphorylation has a clear role in regulating mammalian smooth and nonmuscle myosin II motor function, and is also thought to participate in regulation of filament assembly in nonmuscle cells (36) . Although phosphorylation of the myosin II heavy chain (MHC) has also been observed in several types of mammalian nonmuscle cells in a variety of settings (4, 18, 23, 26) , the de-finitive biochemical consequences of MHC phosphorylation in the mammalian systems are not known.
In Dictyostelium, MHC phosphorylation plays a key role in regulating filament assembly both in vitro and in vivo. Two distinct MHC kinases (MHCKs) have been purified to homogeneity from Dictyostelium. A 84-kD MHCK purified by Ravid and Spudich (28) is expressed only during development. A 130-kD MHCK (MHCK A) purified by Crt6 and Bukiejko (5) is expressed during both growth and developmental stages (Medley, Q. G., S. F. Lee, G. A.
Cates, and G. P. Crtr. 1993. J. CellBiol. 115:29a). Both the 130-kD MHCK A and 84-kD MHCK phosphorylate myosin on threonine residues and can drive myosin filament disassembly in vitro (6, 28) . The 130-kD MHCK A phosphorylates threonine residues 1823, 1833, and 2029 in vitro (22, 37) . The 84-kD MHCK phosphorylates sites within the carboxyl-terminal portion of the myosin molecule (7a, 26a), but its exact target sites have not been mapped. In addition to these two threonine-specific MHCKs, evidence exists for other MHC kinase activities with specificity towards threonine and serine (20, 25) . However, it is not known whether these other in vitro activities have physiological roles in regulating myosin function. The in vivo importance of the mapped MHCK A target sites on the MHC has been demonstrated in studies in which the target sites were converted to either alanine (3X ALA myosin) or to aspartic acid (3X ASP myosin) resi-dues (11) . These substitutions create either a nonphosphorylatable MHC, or pseudophosphorylated MHC, respectively. In vitro the 3X ALA myosin assembles into bipolar filaments as efficiently as wild-type myosin while the 3X ASP myosin is unable to assemble at physiological salt conditions. In vivo 3X ALA myosin dramatically overassembles into the cytoskeleton, while 3X ASP myosin is underassembled relative to wild-type cells. Cells expressing the 3X ALA myosin are competent for myosin dependent contractile events such as cytokinesis and development, although partial defects are apparent. In confocal microscopy studies, cells expressing the 3X ALA MHC display a dramatic over localization of myosin to the cortical regions of the cells (14) . In contrast, cells expressing the 3X ASP MHC are phenotypically identical to MHC null cells (MHC-), indicating that pseudophosphorylated MHC cannot participate in cellular force production. These studies indicate that the mapped MHCK A target sites play a key role in regulating myosin II assembly into the cytoskeleton and that this assembly is required for myosin function in vivo.
At the primary sequence level the 84-kD and 130-kD MHCKs are unrelated. The 84-kD enzyme displays significant similarity to members of the Protein Kinase C (PKC) family, particularly within the catalytic domain (29) . In contrast, the primary sequence of the 130-kD MHCK A displays no significant similarity to any members of the conventional classes of eukaryotic protein kinases. The protein consists of an amino-terminal domain predicted to have an c~-helical coiled-coil structure, a central domain believed to contain the catalytic functions, and a carboxylterminal domain which bears significant similarity to the 13-subunit of heterotrimeric G proteins (13) . In view of the novelty of this enzyme, the MHCK A gene was expressed in E. coli, and studies confirmed that the recombinant protein was able to autophosphorylate and to phosphorylate the Dictyostelium MHC (13).
A major unresolved question concerning myosin regulation in Dictyostelium is the physiological role of the multiple unrelated MHCKs. The studies reported here were designed to elucidate the role that the novel 130-kD MHCK A has in vivo by analyzing MHCK A null cell lines and cell lines overexpressing the cloned MHCK A gene. Data obtained with MHCK A null cell lines and cell lines overexpressing the cloned MHCK A gene demonstrate that this enzyme does exhibit MHC kinase activity in vivo, and that it influences myosin localization and assembly during both growth and development.
Materials and Methods

Dictyostelium Growth and Development
Dictyostelium discoideum strain JH10 (15) was employed as the parental cell type for the studies described here. Cells were cultured axenically on plastic petri dishes in HL5-medium (35) supplemented with 100 U/ml penicillin, 100 ~,g/ml streptomycin, and 100 ixg/ml thymidine. For suspension growth analysis cells were transferred from petri dishes to small Edenmeyer flasks for ~24 h to allow adaptation to suspension growth, and then adjusted to a low cell density. Cultures were rotated at 200 rpm at 21°C and cells were counted daily. Each cell line was inoculated in triplicate and counted independently. Doubling times were determined for cultures during log phase growth, and values from each triplicate culture averaged. For developmental studies cells were harvested in log phase growth and plated on filter membranes as described (35) . The cell line HS1 (31) was used as an MHC-control for some experiments.
Plasmid Constructs and Transformations
All DNA manipulations were performed using standard laboratory methods (32) . Brief description of plasmid constructions are given below. Full details of all constructs are available upon request. To construct an MHCK gene replacement cell line, a gene replacement vector was made as follows. A 0.9-kb ClaI-AccI fragment containing the 5' flanking region of mhck A gene, and a 1.1-kb ClaI-EcoRI fragment containing the 3' portion of the gene were isolated from size selected plasmid libraries of Dictyostelium DNA using the mhck A cDNA as a probe. The gene replacement vector, pDF15, was generated by ligating the 0.9-kb ClaI-AccI fragment and 1.l-kb ClaI-EcoRI fragment into the vector pTZ18 (Pbarmacia Biotech) with the Dictyostelium Thyl gene (9) between the genomic fragments. The Thyl gene was isolated from the plasmid pThy-Short (a gift from K. Ng and G. Nuckolls, Stanford University). The plasmid pThyShort contains the Thyl marker isolated by Dynes and Firtel (9) , except that 1.1 kb of genomic DNA upstream of the Thyl promoter has been removed by Exonuclease III and $1 nuclease digestion as follows. The 3.2-kb Thyl marker from pGEM26 was cloned as an SalI fragment into the XhoI site of pGEM7 (Promega, Madison, WI). This plasmid was digested with EcoRI and Sacl, which both cut the polylinker on the 5' end of the Thyl fragment. Several progressive deletions of the Thyl fragment were created using the Erase-a-Base system (Promega). pThy-Short was the smallest fragment produced in this approach that complimented the Thydefect when transformed into the Dictyostelium cell line JH10.
Plasmid pDF15 was linearized at polylinker restriction sites immediately adjacent to the 5' and 3' segments of homology to promote recombination at the mhck A locus. The thymidine-auxotrophic cell line JH10 was electroporated with 5 g of restricted pDF15 and transformants were selected in HL-5 medium lacking thymidine. Colonies were picked around the seventh day and transferred to 12-well microtiter plates. The isolated colonies were screened for the absence of MHCK A by Western blotting using an anti-MHCK A monoclonal antibody (13) . Of fourteen independent isolates originally screened, twelve showed no reactivity with the anti-MHCK A antiserum. Four of these cell lines were analyzed by Southern blotting and all appeared to be gene replacement events generated via double recombination at the 5' and 3' homology segments. JH10 cells transfected with pThy-Short (referred to as JH10 thy + cells) were used as a control for cell biological studies of mhck A-cells.
Southern Blot Analysis
Genomic Southern blot analysis of the mhck A locus was performed on parental (JH10) and four independent transformed cell lines that had tested negative for MHCK A expression by Western blot analysis. DNA was isolated and purified by CsCI density gradients from parental and MHCK A null cell lines. After digestion of DNA with Xbal, 0.6 ~g DNA was loaded onto a 0.8% agarose gel, electrophoresed, and transferred to GeneScreen Plus membrane (New England Nuclear Research Products, Boston, MA). The filters were hybridized with 32p-labeled cDNA probes following GeneScreen Plus protocols. Probe A is a 1.1-kb ClaI-BclI fragment containing 0.9 kb of mhck A 5' flanking region and 0.2 kb of mhck A coding sequence. Probe B corresponds to a 1.7-kb KpnI-Kpnl restriction fragment of the mhck A cDNA.
MHCK A Overexpressing Cells
The Dictyostelium mhck A cDNA was fused to the Dictyostelium actin 15 promoter, so that codon 8 of the actin 15 gene is fused to codon 7 of mhck A. This modified mhck A gene was then cloned into the expression vector pLittle (constructed by Dr. T. Q. P. Uyeda, NAIR, Japan, unpublished) to generate pLMHCK, pLittle is a derivative of pBIG (31) which contains part of the native Dictyostelium extrachromosomal plasmid Ddp 1, a G418 resistance cartridge, and E. coil replication functions. The plasmid pLittle differs from pBIG in that a 1.5-kb KpnI fragment in the Ddpl portion of pBIG was removed. The plasmid pLMHCK was introduced into the mhck A-cell line by electroporation, grown overnight in HLS, and then transformants were selected in the presence of 8 g/ml G418. Colonies were picked after ~5 d, transferred to microtiter plates for clonal growth, and then screened for the presence of MHCK A by Western blot analysis. In early studies it was demonstrated that the actin 15 promoter expression level increases significantly during development (19) . In more recent studies using this promoter to drive myosin expression from extrachromo-somal plasmids (10, 11, 21) , significant expression has always been observed during growth phase as well.
Generation of Polyclonal Antiserum
A portion of the MHCK A cDNA corresponding to amino acids 7-656 was expressed in E. coli using the expression vector pET21d (Novagen, Madison, WI). The resultant fusion protein contains a (His)6 carboxyl-terminal tag which allows purification using metal ion affinity chromatography methods as described by the pET21 vector supplier. Approximately 200-300 g of affinity-purified protein was injected into a New Zealand white rabbit at 4-wk intervals, with serum collected 12-14 d later. Cleared serum was used at 1:1,000 dilution for Western blots.
Polyclonal antiserum against Dictyostelium myosin was made by injecting rabbits with purified myosin using a similar schedule to that described above. For Western blot analysis the anti-myosin antiserum was used at a 1:1,000 dilution, followed by alkaline pbosphatase conjugated secondary antibody, and development with BCIP (5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt) and NBT (p-nitro blue tetrazolium chloride) (16) .
Western Blot Analysis
Cells were harvested from plates, washed with 15 mM Tris, pH 7.5, and resuspended in buffer containing 50 mM Tris, pH 8.0, 20 mM NaPPi, 5 mM EDTA, 5 mM EGTA, 0.5% Triton X-100, I g/ml leupeptin, 1 g/ml pepstatin, and 10 g/ml PMSF. An equal volume of 2x Sample buffer (50 mM "Iris, pH 6.8, 4% SD8,10% glycerol, 50 l/ml 2-mercaptoethanol, and 0.2 g/ml bromophenol blue) was then added and samples were then immediately boiled for 5 min and subjected to SDS-PAGE. Samples were either stained with Coomassie blue or transferred to nitrocellulose and probed with MHCK A monoclonal or polyclonal antibodies. Signal was detected using either an alkaline phosphatase-linked goat anti-rabbit antibody or ~25I-goat anti-mouse antibody.
Myosin Phosphorylation and Immunoprecipitation
Myosin was phosphorylated in cell lysates as previously described by Betlot et al. (2), with modifications described below. Cells were washed with 15 mM Tris, pH 7.5. 150 txl of cells (3 × 106) in 15 mM Tris were added to 150 txl of a reaction mixture containing 0.2% Triton X-100, 4 mM MgCI2, 4 mM MnC12, 7.5 mM Tris, 10 p,M ATP, and 100 Ci/mmol [~/-3ZP]ATP and incubated on ice for 5 min. Reactions were stopped by adding an equal volume of either ice-cold 5% TCA or 2 x immunoprecipitation buffer (IP) containing 150 mM NaCI, 1% Triton X-100, 15 mM Tris-HC1, pH 7.5, 2 mM NAN3, 5 mM EDTA.
Pansorbin (Calbiochem) (50 1) and anti-myosin polyclonal antiserum (10 1) were mixed with IP buffer (100 1), rotated at 4°C for 4-18 h, and washed three times with IP buffer, Myosin was immunoprecipitated using denaturing conditions. An equal volume of 100 mM Tris, pH 8.0, 10 mM EGTA, 10 mM EDTA, 2% SDS, 4 mM ATP, 100 mM NaF1, 50 mM NaPPi, 10 p,M okadaic Acid, 20 p.g/ml pepstatin, 50 ixg/ml L-l-chloro-3-[4-tosylamido]-7-amino-2-heptanone-HCl (TLCK), and 10 i~g/ml PMSF) was added to the lysates and samples were immediately boiled for 10 min. Pansorbin (4 Ixl) was added and the lysates were cleared by centrifugation at top speed in a microfuge for 5 rain. The supernatant was transferred to a fresh tube containing 1 ml of IP buffer containing the preadsorbed Pansorbin-myosin polyclonal antibody complex described above and mixed overnight with end-over-end rotation at 4°C. The immunoprecipitated myosin was washed as described in (30) with minor modifications. Briefly, the Pansorbin pellet was washed two times with IP buffer containing 0.2% SDS, washed two times with 2 M urea, 200 mM NaC1, 1% Triton X-100, 100 mM Tris-HC1, pH 7.5, 2 mM NAN3, 5 mM EDTA, once with 500 mM NaCI, 1% Triton X-100, 20 mM Tris-HCl, pH 7.5, 2 mM NaN 3, 5 mM EDTA, and once with 50 mM NaCI, 10 mM Tris-HC1, pH 7.5, 2 mM NAN3, 5 mM EDTA. The final complex was then boiled in SDS sample buffer, spun to remove the Pansorbin and soluble material was then subjected to SDS-PAGE.
Phosphoaminoacid Analysis
After SDS-PAGE, myosin was transferred electrophoretically to Immobilon P membrane (Millipore, Bedford, MA) and stained with Ponceau to visualize protein bands. The myosin band was excised, wetted in methanol and rinsed with 1 ml water three times to remove any residual transfer buffer. Phosphoaminoacid Analysis (PPA) was performed according to Boyle et al. (3) . The myosin was hydrolyzed with 5.7 N HCI and incubated for 4 h at ll0°C to optimize for recovery of phosphothreonine. The supernatant was transferred to a fresh tube and lyophilized in a Speed Vac concentrator, and washed three times with 1 ml water. The samples were electrophoresed at pH 1.9 (formic acid/glacial acetic acid/water, 50:156:1794) on cellulose thin-layer plates using the Hunter thin layer electrophoresis unit (CBS Scientific, Del Mar, CA). The positions of the phosphopeptide standards were visualized by staining with 0.25% (wt/vol) ninhydrin in acetone.
Isolation of Triton-insoluble Cytoskeletons
Triton-insoluble cytoskeletons were isolated as described previously (10) with modifications described below. Cells (1.5 x 106) were washed twice in 15 mM Tris, pH 7.5, and resuspended in 150 ~l of 100 mM MES, pH 6.8, 2.5 mM EGTA, 5 mM MgC12 and 2 mM ATP at 0°C. An equal volume of the same buffer containing 1% Triton X-100, 0.1 mg/ml PMSF, 10 mg/ml pepstatin, and 50 p,g/ml TLCK was added. The suspension was vortexed 5 s, and centrifuged for 2 min in a microfuge. Supernatants and Tritoninsoluble pellets were resuspended in SDS gel sample buffer, heated to 100°C for 5 rain, and subjected to SDS-PAGE on 8% gels. Duplicate samples were run, with one set stained with Coomassie blue and the other set used for Western blot analysis. Coomassie blue stained myosin bands from the supernatant and pellet fractions were quantitated by densitometry. The percent myosin in the cytoskeleton was calculated for each individual sample by dividing the value for MHC in the cytoskeletal pellet by the sum of the pellet and supernatant MHC values for that sample. This "%" cytoskeleton value was then averaged for multiple-independent samples to produce the values shown in Fig. 5 C. The "*" for MHCK A ++ cell line values indicate that these are estimates. MHC levels in the cytoskeletal pellets for these cell lines were consistently too low for accurate densitometry from Coomassie-stained gels.
Results
Elimination and Overexpression of MHCK A
The gene encoding MHCK A was eliminated from Dictyostelium by homologous recombination. The gene replacement construct contained the Dictyostelium Thyl gene inserted between 5' and 3' flanking sequences from the mhck A gene (Fig. 1 A) . After introduction of the replacement construct into JH10 cells, 14 transformants were isolated for Western blot analysis with a monoclonal antibody generated against the native MHCK A. Of these cell lines, 12 had no detectable MHCK A expression.
Genomic DNA was isolated from three of the twelve antibody-negative cell lines and used for Southern blot analysis. All three cell lines displayed identical Southern blot profiles. The results for one line are shown in Fig. 1 B. The wild-type mhck A locus resides on an 8-kb XbaI restriction fragment, and in a double cross-over gene replacement, this fragment should be replaced by a 6-kb XbaI restriction fragment containing the Thyl gene (Fig. 1   A) . Filters incubated with a mixed probe comprised of a 5' ClaI-BclI fragment (probe A; see Fig. 1 A) and a central KpnI fragment (probe B) demonstrate the presence of the 8-kb XbaI fragment in the wild-type JH10, and the 6-kb XbaI fragment in the mhck A disruption cell line (Fig. 1   B) . A duplicate filter incubated only with probe B demonstrates the presence of the 8-kb restriction fragment in JH10, but yielded no signal in the mhck A disruption cell line ( Fig. 1 B) , indicating that a clean gene replacement event had occurred. 
Myosin Phosphorylation
Previous studies have demonstrated that the myosin heavy chain is phosphorylated primarily on threonine and serine residues in cells lysed with Triton X-100 containing ['y-a2p]ATP (1, 11). We performed in vitro labeling and phosphoamino acid analysis of myosin isolated from mhck A -and MHCK A + + cell lines to determine what effect alterations in MHCK A abundance would have on phosphorylation in crude lysates. Fig. 3 shows phosphorylation of MHC in Triton X-100 cell lysates from growth phase control, mhck A -and MHCK A ÷+ cell lines. Aliquots of growth phase cells were lysed with Triton X-100 in the presence of [~,-32p]ATP, and then the myosin was immunoprecipitated as described above. Autoradiographic analysis of these samples indicates that the myosin from mhck A -cells was significantly less phosphorylated than myosin from control cells (Fig. 3 B) . In contrast MHCK A ÷÷ cells displayed elevated MHC phosphorylation rela- tive to the control cell line in this assay (Fig. 3 B) . Phosphoaminoacid analysis of immunoprecipitated MHC indicated that the myosin was primarily phosphorylated on threonine residues in control cells, as well as MHCK A + ÷ cells. In experiments performed with significantly higher specific activity [-,/-32p]ATP it was observed that the residual phosphorylation in extracts of rnhck A -cells was also primarily on threonine (data not shown).
We also examined myosin phosphorylation during development of Dictyostelium cells. Control, mhck A-, and MHCK A ÷+ cells were developed on filter pads and harvested at 0, 6, and 16 h into development and phosphorylated in vitro as described above (Fig. 4) . Myosin was immunoprecipitated and subjected to SDS-PAGE followed by staining with Coomassie blue. The level of MHC phosphorylation for each sample (quantified by phosphorimaging) was normalized to the amount of MHC in each sample (quantified by densitometry of the Coomassie-stained gel) so that relative MHC phosphorylation in each sample could be compared. The rate of myosin phosphorylation in crude extracts did not change significantly during development in any of the three cell lines.
Myosin Assembly into the Cytoskeleton in mhck A -and M H C K A ÷ ÷ Cell Lines
To address the localization properties of myosin in mhck A -and MHCK A ÷+ cell lines Triton-insoluble cytoskeletons were isolated from the mutant cell lines. Lysed cells were fractionated by centrifugation into soluble and cytoskeletal components and subjected to SDS-PAGE. Fig. 5 presents a typical cytoskeletal fractionation pattern for growth phase cells after SDS-PAGE and Coomassie blue staining (panel A) or after Western blot analysis (panel B). In control cells the majority of the myosin fractionated in the soluble fraction (Fig. 5, A and B, S lanes), while in mhck A -cells approximately threefold more myosin fractionated with the cytoskeleton (Fig. 5, A and B, P lanes). MHCK A ÷+ cells had most of the myosin associated with the soluble fraction (Fig. 5, A and B, S  lanes) . Quantification of a series of Triton-fractionated samples from both growth phase cells and cells starved for 4 h was performed by densitometry of Coomassie blue-stained gels (Fig. 5 C) . This analysis indicated that in growth phase cells 8.8% (--+1.2) of the myosin from control ceils fractionated with the cytoskeletal fraction, 24.9% (_+2.4) of the myosin from rnhck A -cells fractionated with the cytoskeleton, and <4% of the myosin from MHCK A ++ cell lines fractionated with the cytoskeleton. In control cells starved 4 h 8.0% (_+1.1) of the myosin was associated with the cytoskeleton, while 21.5% (+--1.8) of the myosin from mhck A -cells fractionated with the cytoskeleton. MHCK A ++ cells had <4% of the myosin associated with the cytoskeleton. Therefore, in both growth phase and developed mhck A -cells, myosin consistently overassembled into the cytoskeleton.
Growth Rates and Cytokinesis
The mhck A -and MHCK A + + cell lines grown on plastic petri dishes showed similar growth rates as compared to control cells. To assay competence for cytokinesis, cells were grown in suspension culture as previously described (10, 11) . In this setting myosin function is essential for cell division (7, 24) . When placed in suspension culture, cells lacking myosin II become large and multinucleated, eventually lysing. Parallel suspensions of control (JH10 thy +) and mhck A -cells grew with a doubling time of 10.2 +-_ 0.2 h and 12.3 -+ 0.2 h, respectively (Fig. 6 A) . To directly cornpare growth rates of the MHCK A ÷+ cell line (which carries a G418-resistance extrachromosomal plasmid) to other cell lines, control, mhck A-, and M H C -cells were transfected with the vector pLittle to confer G418 resistance. Analysis of doubling times was then performed with all cell lines in the presence of G418 (8 I~g/ml) to adjust for the slower growth that occurs in the presence of this antibiotic (Fig. 6 B) . Control-pLittle cells doubled every 20.8 ___ 0.5 h while rnhck A--pLittle cells showed a small but reproducible decrease in growth rate in late log phase and doubled every 23.6 -+ 0.7 h. mhck A --pLittle cells remained of normal size, were generally mononucleated, and eventually grew to a similar density as control cells. MHCK A ++ cells displayed a slower than normal growth rate doubling every 27.9 ___ 2.6 h, displayed frequent multinucleation while in suspension culture, and grew to a lower final density as compared to control-pLittle and mhck A--pLittle cells. MHCK A + + cells increased in size during the first several days in suspension and with some cell lysis. However, in contrast to myosin null cell these cells are able to grow in suspension indicating that these cells are at least partially competent to carry out cytokinesis.
Development
Myosin null cells arrest at the mound stage and are unable to complete development, indicating that myosin function is essential for morphogenensis (7) . To assess roles of MHCK A during development, control, mhck A -, and MHCK A++cell lines were allowed to develop on filters.
The mhck A -cells were able to develop normally and formed fruiting bodies at rates (~24 h) comparable to control cells (Fig. 7, A and B ). In addition, mhck A -cells displayed slug migration rates similar to control cells when tested on water-agar plates during phototaxis (35) (data not shown). MHCK A ÷ ÷ cells arrested at the mound stage and were unable to complete development (Fig. 7 C) . In some experiments partial development was observed in MHCK A +÷ cells after 4-5 d on filter pads, but this pattern was not consistent.
Discussion
We have used targeted homologous recombination of the mhck A gene to produce Dictyostelium cells that lack the MHCK A protein. Southern blot analysis of these cells indicated that the mhck A gene was eliminated and a single copy of the Thyl gene was inserted at the mhck A locus. Western blot analysis of the mutant cell lines showed that no MHCK A polypeptide was expressed in mhck A -cells, and revealed a 30-fold increase in MHCK A expression in mhck A -cells transfected with the MHCK A gene on an extrachromosomal vector. The MHCK A protein kinase is unusual in that at the primary sequence level it displays no detectable similarity to known classes of protein kinases (13) . The results presented here provide strong evidence that the biochemically identified MHCK A protein does function as an MHC kinase in Dictyostelium, and that it has a specific role regulating myosin localization in vivo.
In previous studies MHC phosphorylation analysis was performed in crude lysates, or in lysates partitioned into cytoskeletal and soluble fractions (1, 2) . Those studies demonstrated that virtually all MHC kinase activity in crude lysates cofractionates with the Triton-insoluble cytoskeleton. Furthermore, it was observed in those studies that when lysates were prepared from cells stimulated with the chemoattractant cAMP, a transient increase in myosin assembly into the cytoskeleton occurred N40 s after stimulation. This increase in assembled myosin was observed to coincide temporally with an increase in MHC phosphorylation rate in such lysates. It was proposed that myosin assembly into the cytoskeleton in response to cAMP might increase substrate availability to cytoskeletally associated MHC kinase activities, resulting in the observed increase in MHC phosphorylation rate (1) .
The in vitro phosphorylation analysis presented in the current work indicates that the majority of the in vitro MHC kinase activity in Triton X-100 lysates is due to MHCK A. In mhck A -cells, N90% of the MHC kinase activity in such lysates is absent. This result, together with the elevated level of MHC kinase activity in MHCK A++cell lysates, indicates that MHCK A is the major activity that phosphorylates MHC in crude lysates. It is important to note the same pattern was observed in lysates of growth phase cells, and in lysates of cells developed on filter pads for 6 or 16 h. MHCK A appears to be the major MHC kinase activity in crude lysates in all these settings, and appears to be the major activity previously observed in in vitro studies (1) . We believe that in vitro phosphorylation in this assay represents phosphate incorporated into myosin which was not phosphorylated at the time of cell lysis. If MHCK A++cells have elevated levels of in vivo MHC phosphorylation, there may be less available substrate in these extracts, so that the increase in phosphorylation is smaller than one might expect given the 30-fold overexpression of MHCK A in these cells. The converse also may be true in the rnhck A -cells; reduced MHC phosphorylation at MHCK A target sites may allow an increase in the apparent phosphorylation rate in vitro by other kinases present in the mhck A -cells. Cold ATP chase experiments (unpublished observation and see reference 1) indicated very little dephosphorylation of MHC in these Triton extracts, suggesting that no significant turnover of phosphate occurs in these assays.
These results do not preclude roles for other MHC kinase activities in the in vivo control of myosin function. Strong in vitro evidence exists for the importance of the 84-kD PKC-like MHCK in controlling myosin function (28, 29) , and it is likely that the developmentally expressed PKC-like enzyme has developmental-specific roles as well. The predominant role of MHCK A in MHC phosphorylation in crude extracts may be due to either high activity of this enzyme in such lysates, or to a physical interaction between MHCK A and myosin which enhances the relative activity of this kinase in vitro.
The Triton-resistant cytoskeleton analysis of the mhck A-and MHCK A +÷ cell lines provide further evidence that this kinase plays a key role in controlling myosin assembly into the cytoskeleton. Previous analyses of site- directed mutants of MHC phosphorylation sites provide a useful model for assessing the phenotypes of mhck A -and MHCK A ÷÷ cell lines. Cells containing myosin which is nonphosphorylatable at MHCK A target sites (3X ALA cells) or which is pseudophosphorylated by introduction of aspartate residues (3X ASP cells) display overassembly and underassembly of myosin into the cytoskeleton, respectively (11) . In this context the overassembly of MHC into the cytoskeleton in mhck A -cells indicates that MHCK A functions during both growth and development to modulate myosin assembly into the cytoskeleton. This interpretation is further supported by the underassembly of myosin in MHCK A ÷÷ cells. It should be noted that absolute myosin recovery in Triton-cytoskeletal fractions varies depending on exact conditions (ATP concentration, Ca 2+ concentration, temperature, etc.; unpublished observations and see references 8, 11, 33) . Of more importance is the relative difference between different cell lines assayed in parallel under identical conditions. In this regard, clear differences are present between the wild-type, mhck A-, and MHCK A ÷÷ cells.
Analysis of growth rates in suspension revealed a slight but reproducible decrease in rate in mhck A -cells. Although small, this effect is consistent with a modulatory role for MHCK A in either cytokinesis or growth in general. It is noteworthy that a similar but more severe effect was observed previously in the 3X A L A MHC mutants, which display more dramatic myosin overassembly into the cytoskeleton (11) . Cells expressing the 3X A L A MHC had ~80% of cellular myosin associated with the Triton-
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• Control E ~10 6 t~ C Q "10 ~ The relationship between MHCK A and other MHCKs, particularly the 84-kD PKC-like MHCK, is not well understood. In addition to that MHCK, other activities have been observed that phosphorylate MHC on serine as well as threonine (20, 25) . A firm understanding of the relationships between these kinases will require cloning and gene disruption of the genes encoding these activities. A notable discrepancy between the properties of 3X ALA cells and rnhck A-cells is that the former cells assemble ~80% of their myosin into Triton-resistant cytoskeletons while the latter ceils assemble only ~25%. While there is clear overassembly of myosin in the mhck A-cells, this difference implies that there are other physiologically important MHC kinases which participate in regulation of myosin localization during both growth and developmental stages. These results also imply that the other activity or activities phosphorylate the same target sites that were originally mapped in vitro for MHCK A (residues 1823, 1833, and 2029), as removal of these target sites eliminates control of localization in vivo (e.g., 3X ALA myosin).
Overall these results indicate a role for MHCK A in regulating myosin localization during both growth and development, but also indicate a role for other kinases. Further analysis of the relative roles of the 84-kD PKC-like MHCK vs other partially characterized activities wilt help establish the general mechanism by which Dictyostelium cells regulate myosin function and localization.
